James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why BP plc (ADR) (BP), L Brands Inc (LB) and Tesla Motors Inc (TSLA) Are 3 of Today’s Worst Stocks

BP, L Brands (LB) and Tesla Motors (TSLA) were in the wrong place at the wrong time on Tuesday. Here's what you need to know.

Twilio Inc (TWLO) Stock Is Dead Money Until This Happens

The disconnect between TWLO the company and Twilio stock is presenting the market with a big conundrum. Here's what you need to know.

Valeant Pharmaceuticals Intl Inc (VRX) Is What’s Wrong With America

Valeant Pharmaceuticals have made bad choices that have punished VRX stock holders. But those investors are hardly alone anymore.

Why Centurylink Inc (CTL), Baker Hughes Incorporated (BHI) and Zimmer Biomet Holdings Inc (ZBH) Are 3 of Today’s Worst Stocks

Owners of Zimmer Biomet (ZBH), Centurylink (CTL) and Baker Hughes (BHI) were tricked, rather than treated, on Monday.

Nike Inc (NKE) Stock Is Ready for a BIG Comeback

Nike stock has been a poor performer for a year now, but NKE has been doing just fine. Time for the market to figure it out.